Conference abstractPublished 21 Oct 2013
Enhancing the regulatory approval of herbal medicine: The place of toxicogenomics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Medicinal plants constitute a source of raw materials for both traditional and modern medicine. Globally, traditional medicine has been accepted as one of the ways that individuals seek remedies for all kinds of medical problems ranging from simple headache to severe and terminal disease such as cancer. The wide usage of herbal medicine has contributed greatly to the growth of the global pharmaceutical market. The use of herbal medicine has been driven by poor medical facilities across Africa, high cost of orthodox medicine, inadequate medical facilities and ease of accessibility, affordability and availability. Though the claims of most traditional herbal practitioners may be unquestionable, the world and users of the product have to be convinced of their efficacy, efficiency and safety using modern toxicological techniques and clinical research. In most biomedical research evaluating medicinal products in Africa and possibly elsewhere in the world, acute toxicological testing using animal models have prevailed. Recent findings have shown that data generated from animal studies may not directly be extrapolated in human subjects. Developing herbal medicines thus requires research technique which is able to predict toxicities as early as possible. Could regulatory agencies adopt toxicogenomics screening as a faster and cost saving technique when approving herbal products in this region? Are there advantages to be derived when this technique is used? How will practitioners benefit from this emerging technique? The aim of this presentation is to discuss the above issues hoping that the knowledge if applied in the broader diagnostic scope shall help greatly in the regulatory process of herbal products.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Augustine A. Onyeaghala”
